Since PD-L1 was ineffective in WT mice on tumor progression, we conclude that MT sensitized the mice to PD-L1 treatment, but by promoting more rapid tumor progression which was then ameliorated by PD-L1. The gene discussed is CD274; the disease is neoplasm.